📰 Bin Chen News
Page 3 - Bin Chen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bin Chen. Real-time updates on events, politics, business and more.
January 11, 2024
The expert panel explores the immunological aspects of chronic GVHD, highlighting challenges in simultaneous management, addressing fibrosis, and emphasizing the importance of early intervention in evolving transplant care practices.
January 11, 2024
Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz distinguish acute from chronic graft-versus-host disease (GVHD), how such distinction has changed over the last decades, and provide an overview of consensus definitions for disease grading.
December 24, 2023
Certain Common Stock of NETSTARS Co.,Ltd. are subject to a Lock-Up Agreement Ending on 24-DEC-2023. These Common Stock will be under lockup for 89 days starting from 26-SEP-2023 to...
November 20, 2023
Northwestern University researchers have once again elevated the benchmarks for perovskite solar cells, achieving new efficiency records through a groundbreaking development in the emerging technology.
November 18, 2023
Northwestern University researchers have raised the standards again for perovskite solar cells with a new development that helped the emerging technology hit new records for efficiency.
November 5, 2023
Radio astronomers in California imaged the suns scorching hot corona for the first time ever during a partial solar eclipse on Oct. 14.
October 26, 2023
Scientists used the new Owens Valley Radio Observatory Long Wavelength Array (OVRO-LWA) in California to capture radio images of October's annular eclipse.
October 25, 2023
Scientists used the new Owens Valley Radio Observatory Long Wavelength Array (OVRO-LWA) in California to capture the first-ever radio images of an annular solar eclipse.
October 24, 2023
Researchers have captured the first-ever radio images of an annular eclipse, showcasing the famous "ring of fire" effect.
August 14, 2023
/PRNewswire/ -- ImmunoFree, Inc. announced today that it has acquired all right to FCR001, a cellular therapy product, and the sponsorship of the FREEDOM-1...